Search company, investor...
Datar Genetics company logo

Datar Genetics

Founded Year


About Datar Genetics

Datar Genetics is a center for molecular and genetic analysis.

Headquarters Location




Missing: Datar Genetics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Datar Genetics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Datar Genetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Datar Genetics is included in 3 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



105 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'


Health IT

7,901 items

Latest Datar Genetics News

You can now detect over 70 types of cancer with one blood test

Sep 14, 2022

LifeGen partners with Datar Genetics to diagnose late cancer through the use of Trucheck blood test September 14, 2022 Lifegen, a UAE-based company providing cancer detection and management solutions, partners with Datar Cancer Genetics to enable access to Trucheck. Trucheck is a highly accurate blood-based multi-cancer screening test which can potentially be the solution to the massive problem of late diagnosis of cancer in the region. The progressive CE-marked test provides early diagnosis of over 70 types of cancer and is able to test with 96 per cent accuracy and 99 per cent specificity. Infact, Trucheck can be combined with existing annual health check-up programs across healthcare groups, corporates and insurances. Private hospitals across Abu Dhabi and Dubai will be the first to offer the test to patients. According to the World Health Organisation, long-term projections show that by 2030 there would be a 1.8-fold increase in cancer incidences. The partnership between LifeGen and Datar Cancer Genetics represents a pivotal step towards early cancer detection, beyond the current screening age invitation, allowing individuals the reassurance with one single sample of blood. Generally, the traditional methods for cancer screening are intrusive, inconvenient and can be painful. It involves potential exposure to radiation followed by a nerve-wracking wait until results are collected. While, Trucheck’s test screens over 70 different types of cancers in an individual using a single blood sample, collecting 15-20ml of blood to detect the presence of CTC (Circulating Tumor Cells). This helps in early-stage diagnosis and provides results to patients as quick as 10-12 days. Individuals have the option to take the multi-cancer test or a cancer-specific test which includes single options such as prostate, breast, bowel or even a group of cancers found more actively in diabetic patients. Datar’s tests for early detection of breast and prostate cancer have been granted ‘Breakthrough Designation’ by the US FDA. Trucheck’s accuracy, sensitivity and specificity are confirmed by testing over 50,000 individuals who synchronously screened for cancer, using conventional screening modalities, such as X-ray, CT scan or colonoscopy. Dr. Ramin Ajami, founder of LifeGen said, “We have launched LifeGen in the region with the aim of providing the opportunity to spot early-stage tumors and tackle any issues at the earliest stage possible in order to bypass significant problems that may occur in someone’s future. With the use of the world-leading science behind Trucheck blood tests, we are able to detect tumors at a very early stage where there are significantly more effective solutions and reduced stresses for the individuals.” Tags

Datar Genetics Frequently Asked Questions (FAQ)

  • When was Datar Genetics founded?

    Datar Genetics was founded in 1992.

  • Where is Datar Genetics's headquarters?

    Datar Genetics's headquarters is located at Nashik.

  • Who are Datar Genetics's competitors?

    Competitors of Datar Genetics include Epigeneres Biotech.

Compare Datar Genetics to Competitors

Epigeneres Biotech

Epigeneres is a leading biotechnology company that discovers, develops, manufactures and commercializes molecular medicines and nutrigenomic formulations for the treatment and prevention of serious medical conditions like cancer, and diseases of ageing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.